Achillion, Gilead drug cocktail cures hepatitis C in six weeks

February 9, 2015 11:51 AM

10
0

(Reuters) - Achillion Pharmaceuticals Inc said its experimental hepatitis C drug, when used in combination with Gilead Sciences Inc's Sovaldi, eradicated signs of the virus after six weeks of therapy, sending its shares up before the opening bell.

If the combination of Sovaldi and Achillion's ACH-3102 continues to show this level of effectiveness, the treatment could eventually rival offerings from Gilead and AbbVie Inc to fight the liver-destroying virus.